SCHEMBL20734941

SCHEMBL20734941

CC(C)(C)OC(=O)N1C(=O)C=C(OCc2ccc(C#N)cc2)[C@@H]1Cc1ccccc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KLK7 P49862 8/20 0.46
GPR119 Q8TDV5 1/20 0.44
KLK5 Q9Y337 7/20 0.43
PRSS1 P07477 3/20 0.42
PRSS2 P07478 3/20 0.42
PRSS3 P35030 3/20 0.42
MAOB P27338 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.40
P2RX7 Q99572 1/20 0.38
RAB9A P51151 1/20 0.37
YAP1 P46937 1/20 0.37
GAA P10253 1/20 0.36
CRHBP P24387 1/20 0.36
CRHR2 Q13324 1/20 0.36
RXFP1 Q9HBX9 1/20 0.36
PLA2G10 O15496 1/20 0.36
PLA2G5 P39877 1/20 0.36
MEN1 O00255 1/20 0.36
KMT2A Q03164 1/20 0.36
KDM4C Q9H3R0 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20734942 1.00 KLK7 (0.46) KLK7GPR119KLK5PRSS1PRSS2
SCHEMBL20734893 0.88 KLK7 (0.49) KLK7KLK5PRSS1PRSS2PRSS3
SCHEMBL20734811 0.88 KLK7 (0.49) KLK7KLK5PRSS1PRSS2PRSS3
SCHEMBL20734886 0.87 KLK7 (0.48) KLK7KLK5PRSS1PRSS2PRSS3
SCHEMBL20734889 0.86 KLK7 (0.48) KLK7KLK5PRSS1PRSS2PRSS3
SCHEMBL20734890 0.86 KLK7 (0.48) KLK7KLK5PRSS1PRSS2PRSS3
SCHEMBL20734905 0.84 KLK7 (0.46) KLK7KLK5PRSS1PRSS2PRSS3
SCHEMBL20734810 0.84 KLK7 (0.46) KLK7KLK5PRSS1PRSS2PRSS3
SCHEMBL22064295 0.84 KLK7 (0.46) KLK7KLK5PRSS1PRSS2PRSS3
SCHEMBL22064650 0.84 KLK7 (0.46) KLK7KLK5PRSS1PRSS2PRSS3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11130733-B2 4-OXO-alkylated tetramic acid compound, preparation method and use thereof BEIJING JOEKAI BIOTECH. LLC (CN) 2021-09-28 US disclosed
US-20200361868-A1 4-OXO-ALKYLATED TETRAMIC ACID COMPOUND, PREPARATION METHOD AND USE THEREOF BEIJING JOEKAI BIOTECH. LLC (CN) 2020-11-19 US disclosed
WO-2019029274-A1 4-OXO-ALKYLATED TETRAMIC ACID COMPOUND AND PREPARATION METHOD THEREFOR 北京卓凯生物技术有限公司 2019-02-14 WO disclosed
WO-2019029273-A1 4-OXO-ALKYLATED TETRAMIC ACID COMPOUND, PREPARATION METHOD THEREFOR AND USE THEREOF 北京卓凯生物技术有限公司 2019-02-14 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11130733-B2 4-OXO-alkylated tetramic acid compound, preparation method and use thereof HTT, PARK7, PSEN1 KLK7 4130/4885GPR119 429/4885KLK5 3583/4885
US-20200361868-A1 4-OXO-ALKYLATED TETRAMIC ACID COMPOUND, PREPARATION METHOD AND USE THEREOF HTT, PARK7, PSEN1 KLK7 4130/4885GPR119 429/4885KLK5 3583/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.